SWEDISH PHARMACEUTICAL COMPANY FILES ACTION AGAINST U.S .GENERIC DRUG COMPANIES

Swedish Pharmaceutical giant AstraZeneca , plans to sue seven generic drug manufacturers

in the U.S. to defend it's patent of CRESTOR. The generic drugs are made by companies when the patent expires.

The action was filed in the Delaware U.S. District Court. Crestor is one of AstraZeneca's 5 top selling drugs. The company has seen profits sink to1.34 billion dollars. In the future they plan to cut 7,600 jobs.